High missingness was observed for relevant biomarkers (AST, ALT and Plt) indicative of liver health, which are used to score fibrosis and cirrhosis stage and we therefore could not validate/modify HCC risk scores. The gene discussed is GPT; the disease is hepatocellular carcinoma.